Details of the Drug

General Information of Drug (ID: DM2BLMT)

Drug Name
ABT-199
Indication
Disease Entry ICD 11 Status REF
Chronic lymphocytic leukaemia 2A82.0 Phase 3 [1]
Cross-matching ID
PubChem CID
49846579
TTD ID
D00NPO
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Clinical pipeline report, company report or official report of Abbott Laboratories.